Ironwood Appoints Tammi Gaskins as New CEO
Ironwood Pharmaceuticals appointed Chief Commercial Officer Tammi Gaskins to succeed retiring CEO Tom McCourt as of January 1, 2027. The appointment signals a strategic leadership transition aimed at continuing the company's growth momentum in GI and rare disease therapies.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed